NGL Fine Chem Intrinsic Value

NGLFINE • Healthcare
Current Stock Price
₹1424.70
Primary Intrinsic Value
₹1371.04
Market Cap
₹427.4 Cr
-3.8% Downside
Median Value
₹1371.04
Value Range
₹427 - ₹2849
Assessment
Trading Near Calculated Value
Safety Margin
-3.9%

NGLFINE Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹1371.04 ₹1096.83 - ₹1645.25 -3.8% EPS: ₹62.32, Sector P/E: 22x
Book Value Method asset ₹1880.00 ₹1692.00 - ₹2068.00 +32.0% Book Value/Share: ₹940.00, P/B: 2.0x
Revenue Multiple Method revenue ₹2849.40 ₹2564.46 - ₹3134.34 +100.0% Revenue/Share: ₹1626.67, P/S: 2.0x
EBITDA Multiple Method earnings ₹2506.50 ₹2255.85 - ₹2757.15 +75.9% EBITDA: ₹76.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹1225.47 ₹980.38 - ₹1470.56 -14.0% CF Growth: 7.5%, Discount: 15%
PEG Ratio Method growth ₹427.41 ₹384.67 - ₹470.15 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹962.84 ₹866.56 - ₹1059.12 -32.4% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹1600.00 ₹1440.00 - ₹1760.00 +12.3% ROE: 14.2%, P/E Multiple: 12x
Graham Defensive Method conservative ₹1148.07 ₹1033.26 - ₹1262.88 -19.4% EPS: ₹62.32, BVPS: ₹940.00
Dividend Yield Method dividend ₹427.41 ₹384.67 - ₹470.15 -70.0% DPS: ₹1.75, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check NGLFINE share price latest .

Valuation Comparison Chart

NGLFINE Intrinsic Value Analysis

What is the intrinsic value of NGLFINE?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of NGL Fine Chem (NGLFINE) is ₹1371.04 (median value). With the current market price of ₹1424.70, this represents a -3.8% variance from our estimated fair value.

The valuation range spans from ₹427.41 to ₹2849.40, indicating ₹427.41 - ₹2849.40.

Is NGLFINE undervalued or overvalued?

Based on our multi-method analysis, NGL Fine Chem (NGLFINE) appears to be trading near calculated value by approximately 3.8%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 7.34 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.54 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 14.2% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 14.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.13x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹36 Cr ₹19 Cr Positive Free Cash Flow 8/10
March 2024 ₹21 Cr ₹8 Cr Positive Free Cash Flow 7/10
March 2023 ₹35 Cr ₹22 Cr Positive Free Cash Flow 8/10
March 2022 ₹14 Cr ₹7 Cr Positive Free Cash Flow 7/10
March 2021 ₹27 Cr ₹15 Cr Positive Free Cash Flow 8/10